Literature DB >> 31730871

Spatiotemporal quantification of gait in common marmosets.

Kristen A Pickett1, Nancy Schultz-Darken2, Abigail F Bradfield3, Kerri Malicki2, Bruce Pape2, Karla K Ausderau4, Marina E Emborg5.   

Abstract

BACKGROUND: Objective gait evaluation in humans is used as a predictive disability outcome measure as well as an indicator for intervention effectiveness. Parallel methods of gait analysis in nonhuman primate models are essential for clinical translation. The goal of this study was to first assess whether marmosets' gait data could be reliably collected in a Noldus CatWalk XT10.6 and second, establish a testing protocol to assess gait and the intraindividual variability during repeated testing. NEW
METHOD: The CatWalk, originally developed for rodents, was modified and used to assess gait in eight adult common marmoset monkeys across multiple days and trials. Data was first analyzed to identify valid runs. Repeated measures ANOVA was completed for the following gait measures: mean base of support, average stride length, average swing time, and average stance time.
RESULTS: Raters had a high level of concurrence of usable data across all trials with successful trials including four consecutive hindfoot footfalls, during a continuous, uninterrupted segment of walking. A significant main effect of time (p < 0.000) but not rater (p = 0.98) was present with significant interactions for time by subject (p < 0.000), but not rater per subject (p = 0.538), time (p = 0.186), or three-way interaction (p = 0.297). COMPARISON WITH EXISTING METHOD(S): Gait has been assessed using force-plate and video data. The CatWalk allowed reproducible, automated and translational locomotor data to be collected at multiple time points with detailed analyses that identified a diagonal gait pattern.
CONCLUSIONS: The CatWalk system, similar to those used in humans, can be effectively used to quantify spatiotemporal characteristics of gait in the common marmoset.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Common marmosets; Duty cycle; Gait; Locomotion; Monkeys; Stride

Year:  2019        PMID: 31730871      PMCID: PMC7012682          DOI: 10.1016/j.jneumeth.2019.108517

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  33 in total

1.  Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease.

Authors:  Ryan P Duncan; Gammon M Earhart
Journal:  Neurorehabil Neural Repair       Date:  2011-09-29       Impact factor: 3.919

2.  Impact of limiting visual input on gait: Individuals with Parkinson disease, age-matched controls, and healthy young participants.

Authors:  Laura M Pilgram; Gammon M Earhart; Kristen A Pickett
Journal:  Somatosens Mot Res       Date:  2016-03-18       Impact factor: 1.111

3.  Gait variability in Parkinson's disease: levodopa and walking direction.

Authors:  M S Bryant; D H Rintala; J G Hou; R L Collins; E J Protas
Journal:  Acta Neurol Scand       Date:  2015-09-23       Impact factor: 3.209

4.  Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease.

Authors:  Terry D Ellis; James T Cavanaugh; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Anne Thackeray; Matthew S Thiese; Leland E Dibble
Journal:  Parkinsonism Relat Disord       Date:  2016-02-02       Impact factor: 4.891

5.  Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease.

Authors:  Rossitza Baltadjieva; Nir Giladi; Leor Gruendlinger; Chava Peretz; Jeffrey M Hausdorff
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

Review 6.  Contributions of non-human primates to neuroscience research.

Authors:  John P Capitanio; Marina E Emborg
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

7.  Gait asymmetry in community-ambulating stroke survivors.

Authors:  Kara K Patterson; Iwona Parafianowicz; Cynthia J Danells; Valerie Closson; Mary C Verrier; W Richard Staines; Sandra E Black; William E McIlroy
Journal:  Arch Phys Med Rehabil       Date:  2008-02       Impact factor: 3.966

8.  Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease.

Authors:  K K Hill; M C Campbell; M E McNeely; M Karimi; M Ushe; S D Tabbal; T Hershey; H P Flores; J M Hartlein; H M Lugar; F J Revilla; T O Videen; G M Earhart; J S Perlmutter
Journal:  Exp Neurol       Date:  2012-12-19       Impact factor: 5.330

9.  Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.

Authors:  Lars Tatenhorst; Katrin Eckermann; Vivian Dambeck; Luis Fonseca-Ornelas; Hagen Walle; Tomás Lopes da Fonseca; Jan C Koch; Stefan Becker; Lars Tönges; Mathias Bähr; Tiago F Outeiro; Markus Zweckstetter; Paul Lingor
Journal:  Acta Neuropathol Commun       Date:  2016-04-22       Impact factor: 7.801

10.  Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.

Authors:  Rosie Morris; Sue Lord; Rachael A Lawson; Shirley Coleman; Brook Galna; Gordon W Duncan; Tien K Khoo; Alison J Yarnall; David J Burn; Lynn Rochester
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-11-09       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.